ADAM9 and esophageal squamous cell carcinoma: Among early stage ESCC patients (stage I and II), those with positive ADAM9 staining had a shorter survival time compared with the ADAM9-negative group (Figure 1C), but that trend was not observed in late stages (stage III and IV, Figure S1), probably due to the very short survival time of late stage-patients.